Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Lymphoma, Lymphoblastic
and you are
between 18 and 65
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

This study evaluates the efficacy and tolerability of treatment for T-lymphoblastic lymphoma (T-LBL) according to modified BFM-95 regimen for acute lymphoblastic leukemia.

Provided treatments

  • Drug: induction
  • Drug: induction
  • Drug: protocol M
  • Drug: maintenance therapy
  • Drug: reinduction
  • Drug: reinduction
  • Drug: Intrathecal (IT)
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02396043. The sponsor of the trial is Sun Yat-sen University and it is looking for 50 volunteers for the current phase.
Official trial title:
Modified BFM-95 Regimen for the Treatment of Newly Diagnosed T-lymphoblastic Lymphoma in Adults:a Prospective Phase II Study